Trenbolone
Also known as: Tren, Tren A, Tren E, Trenbolone Acetate, Trenbolone Enanthate, Finaplix, Parabolan, Trenbolone Hexahydrobenzylcarbonate
19-Nor Anabolic-Androgenic Steroid | Potent Recomposition Agent
Overview
Trenbolone is a synthetic 19-nortestosterone derivative and one of the most potent anabolic-androgenic steroids in common use. Originally developed for veterinary applications -- specifically as the implant pellet product Finaplix for increasing feed efficiency and lean mass in cattle -- trenbolone has never been approved for human medical use. The sole exception was a brief period in the 1980s and 1990s when trenbolone hexahydrobenzylcarbonate was marketed as Parabolan in France for human clinical use, primarily for muscle wasting and cachexia, before being voluntarily discontinued. Trenbolone's pharmacological profile is remarkable: it exhibits approximately five times the anabolic and androgenic potency of testosterone, reflected in its anabolic:androgenic ratio of 500:500 compared to testosterone's 100:100. This extraordinary potency stems from three conjugated double bonds in its steroid nucleus that dramatically enhance androgen receptor binding affinity. Unlike its parent compound nandrolone, trenbolone does not aromatize to estrogen, which contributes to its pronounced ability to produce lean, dry gains without significant water retention. However, trenbolone does exhibit significant progestogenic activity, which can elevate prolactin levels and produce a distinct set of side effects unrelated to estrogen. Trenbolone is widely regarded as the most powerful commonly available anabolic steroid for body recomposition -- simultaneously building muscle while reducing body fat. This reputation comes at a considerable cost: trenbolone carries one of the harshest side effect profiles of any steroid, including insomnia, night sweats, cardiovascular strain, respiratory distress upon injection (tren cough), anxiety, and aggression. It is strictly an advanced-only compound that should never be used by beginners or individuals without extensive experience managing anabolic steroid cycles and their ancillary requirements.
Key benefits
- Exceptional lean muscle mass accrual with minimal water retention due to non-aromatizing profile
- Dramatic body recomposition capability -- simultaneous muscle gain and fat loss even in caloric deficit
- Approximately five times the anabolic and androgenic potency of testosterone (500:500 ratio)
- Powerful anti-catabolic effects through glucocorticoid receptor antagonism, protecting muscle during dieting
- Significant increases in strength across all compound movements, often rapid in onset
- Enhanced nutrient partitioning, directing calories toward lean tissue accretion over fat storage
- Pronounced muscle hardness, density, and vascularity due to absence of estrogenic water retention
- Increased IGF-1 production in muscle tissue, amplifying growth signaling pathways
Mechanism of action
Trenbolone binds to the androgen receptor with approximately three to five times the affinity of testosterone, making it one of the strongest known AR agonists among anabolic steroids. This exceptional binding affinity drives potent activation of AR-dependent gene transcription, resulting in dramatically enhanced nitrogen retention, protein synthesis, and satellite cell proliferation in skeletal muscle. Trenbolone also powerfully inhibits glucocorticoid receptors, reducing cortisol-mediated catabolism and shifting the body's metabolic environment decisively toward anabolism even during caloric restriction -- a property central to its reputation as a recomposition agent. The compound significantly increases IGF-1 expression in muscle tissue, further amplifying its anabolic signaling cascade. A distinguishing feature of trenbolone is its complete resistance to aromatization. The conjugated double bond system in the A-ring prevents interaction with the aromatase enzyme, meaning trenbolone produces no estrogenic metabolites. This eliminates estrogen-mediated water retention and fat deposition but does not protect against gynecomastia, because trenbolone activates progesterone receptors at meaningful affinity. Progesterone receptor activation can sensitize breast tissue to circulating estrogen (from a concurrent testosterone base) and independently elevate prolactin levels, potentially causing lactation, sexual dysfunction, and mood disturbance. Trenbolone also strongly increases nutrient partitioning efficiency, directing calories preferentially toward muscle protein synthesis rather than adipose storage. This effect, originally exploited in cattle feed lots to produce leaner beef, translates to the dramatic body recomposition effects observed in human users. Unlike nandrolone, trenbolone is not meaningfully metabolized by 5-alpha reductase. In fact, 5-alpha reductase inhibitors like finasteride do not reduce trenbolone's androgenic activity and can paradoxically worsen androgenic side effects, because trenbolone's own metabolites (produced through different enzymatic pathways) are more androgenic than the parent compound in certain tissues. Trenbolone's impact on the cardiovascular system is notably severe: it reduces HDL cholesterol, increases LDL cholesterol, promotes left ventricular hypertrophy, and may directly damage cardiac tissue through mechanisms independent of its effects on lipids.
Molecular data
- Type
- 19-nortestosterone derivative (C18H22O2), trienone steroid
- Half-life
- ~3 days (acetate)
Indications
What the research community uses this compound for, with self-reported effectiveness.
Body Composition
Advanced Recomposition
Most effectiveTrenbolone's combination of extreme anabolic potency, anti-catabolic glucocorticoid receptor antagonism, and enhanced nutrient partitioning makes it the most effective single compound for simultaneous muscle gain and fat loss. Users routinely report adding lean tissue while losing body fat at maintenance or even slight deficit calories. This effect is most pronounced in experienced users with a solid training and nutrition foundation.
Contest Preparation / Cutting
Most effectiveThe non-aromatizing profile eliminates estrogen-driven water retention, producing a hard, dry, and vascular appearance. Combined with its muscle-sparing anti-catabolic properties, trenbolone is a cornerstone of competitive bodybuilding contest preparation stacks. It preserves maximal lean mass during aggressive caloric deficits.
Lean Bulking
Most effectiveAt moderate to high doses combined with a caloric surplus and testosterone base, trenbolone drives substantial lean mass gains with significantly less water and fat accumulation than aromatizing compounds. Weight gained on trenbolone is predominantly contractile tissue.
Strength Performance
Maximal Strength
Most effectiveTrenbolone produces rapid and significant strength increases through enhanced neuromuscular efficiency, increased nitrogen retention, and elevated IGF-1. Strength gains often manifest within the first two to three weeks, particularly with the fast-acting acetate ester. Users commonly report personal records across major compound lifts.
Strength During Caloric Deficit
EffectiveOne of trenbolone's most valued properties is its ability to maintain or even increase strength during caloric restriction. The glucocorticoid receptor antagonism and potent anabolic signaling counteract the catabolic environment of dieting, allowing users to train at or near peak intensity while cutting.
Veterinary
Cattle Feed Efficiency (Finaplix)
Most effectiveTrenbolone acetate was originally developed and is still primarily used as a veterinary implant to increase feed efficiency and lean muscle mass in beef cattle. Finaplix pellets are implanted subcutaneously in the ear, producing significant increases in growth rate and protein accretion while reducing fat deposition. This remains the only fully approved use of trenbolone.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Trenbolone is administered exclusively via intramuscular injection. Three ester formulations exist: trenbolone acetate, the most commonly used form with a short half-life requiring every-other-day injections; trenbolone enanthate, a longer ester allowing twice-weekly injections; and trenbolone hexahydrobenzylcarbonate (Parabolan), a long ester that was briefly used in human medicine. Acetate is strongly preferred for first-time trenbolone users because its rapid clearance (~3 days) means that if severe side effects develop, the compound exits the system relatively quickly upon discontinuation. All trenbolone use requires a concurrent testosterone base.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Recomposition - Moderate (Acetate) Standard moderate trenbolone acetate protocol. Must be run with a testosterone base, typically at TRT levels (100-200 mg/week) to minimize aromatization while maintaining physiological androgen support. Have cabergoline on hand for prolactin management. 8-10 week cycle length. This is the recommended starting point for users new to trenbolone -- though they should not be new to steroids in general. | 200-300 mg/week (50-75 mg every other day) | Every other day | Intramuscular |
| Advanced Cutting (Acetate) Higher-dose acetate protocol for experienced users during aggressive fat loss phases. Testosterone base kept at TRT (100-200 mg/week) to minimize estrogen and water. Often stacked with a thermogenic such as clenbuterol. Side effects are significantly more pronounced at this dose range. Prolactin monitoring via bloodwork is essential. | 300-400 mg/week (75-100 mg every other day) | Every other day | Intramuscular |
| Lean Bulk (Enanthate) Trenbolone enanthate for users who prefer less frequent injections during a lean gaining phase. Testosterone base at TRT to moderate levels. Cycle length of 10-12 weeks. The longer ester means side effects take longer to resolve if discontinuation is needed -- not recommended for first-time trenbolone users. | 200-400 mg/week | 2x per week | Intramuscular |
| Contest Preparation - Advanced High-dose protocol reserved for competitive bodybuilders with extensive steroid experience and comprehensive bloodwork monitoring. Often combined with other non-aromatizing compounds. Requires prolactin management, cardiovascular monitoring, and careful attention to mental health. Duration limited to 8-10 weeks at these doses. | 300-500 mg/week | Every other day (acetate) or 2x per week (enanthate) | Intramuscular |
Preparation
You will need
- Trenbolone vial (typically 100-200 mg/mL in carrier oil)
- Syringes (1 mL or 3 mL)
- Drawing needle (18-21 gauge)
- Injection needle (22-25 gauge for IM)
- Alcohol swabs
- Sharps container
Steps
- Wash hands thoroughly and prepare a clean work surface
- Wipe vial stopper with alcohol swab and allow to dry
- Draw air into syringe equal to the volume of trenbolone to be withdrawn
- Insert drawing needle through vial stopper and inject air to equalize pressure
- Invert vial and withdraw the prescribed dose, tapping to remove air bubbles
- Switch to injection needle (do not inject with drawing needle)
- Clean injection site with alcohol swab in circular motion outward
- Insert needle at 90-degree angle into ventrogluteal, vastus lateralis, or deltoid muscle
- Inject slowly over 15-30 seconds; slow injection speed may help reduce the incidence of tren cough
- Withdraw needle, apply gentle pressure with gauze, dispose of needle in sharps container
- Note: 'Tren cough' -- a brief but intense coughing fit -- can occur immediately after injection if a small amount of oil enters a blood vessel. It is self-limiting and typically resolves within 30-90 seconds.
Work out the water volume and syringe units in the reconstitution calculator →
Protocol variations
Alternative cycling patterns reported in the literature and community.
Trenbolone Acetate
Trenbolone acetate is the gold standard ester for this compound. Originally sourced from Finaplix cattle implant pellets (which were converted into injectable preparations), pharmaceutical-grade acetate is now produced by numerous underground laboratories. The short ester chain provides rapid onset of action, with peak blood levels reached within 24-48 hours of injection. The most significant practical advantage is manageability: because the ester clears quickly, users who experience intolerable side effects -- severe insomnia, extreme anxiety, cardiovascular distress -- can discontinue and expect meaningful symptom resolution within 5-7 days. This quick-exit option is not available with longer esters.
Trenbolone Enanthate
Trenbolone enanthate attaches the same long-chain ester used on testosterone enanthate, extending the half-life to approximately 10-14 days. This allows for twice-weekly injections and more stable blood levels with fewer peaks and troughs. However, the extended half-life is a double-edged sword: while it offers convenience, it means that if a user experiences severe side effects, the compound remains active in the body for weeks after the last injection. For this reason, trenbolone enanthate is recommended only for users who have prior experience with trenbolone acetate and have confirmed they tolerate the compound acceptably. Trenbolone enanthate has never been manufactured by any pharmaceutical company; all sources are underground laboratories.
Trenbolone Hexahydrobenzylcarbonate (Parabolan)
Trenbolone hexahydrobenzylcarbonate, marketed as Parabolan, holds a unique place in trenbolone's history as the only ester ever approved and manufactured for human clinical use. Produced by Negma Laboratories in France, it was prescribed for muscle wasting, cachexia, malnutrition, and osteoporosis from 1980 until its voluntary discontinuation in 1997. The hexahydrobenzylcarbonate ester provides a half-life similar to enanthate (approximately 14 days), supporting twice-weekly or even once-weekly injection schedules. While 'Parabolan' remains a widely used label among underground laboratories, no legitimate pharmaceutical product exists today. Any product labeled as Parabolan is a UGL reproduction. Historically, Parabolan was dosed at 76 mg per 1.5 mL ampule (equivalent to 50 mg of trenbolone base per ampule).
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Finasteride
Avoid5-alpha reductase inhibitors must be avoided with trenbolone. Unlike testosterone, where 5-AR inhibitors reduce conversion to the more potent DHT, trenbolone is not primarily metabolized by 5-alpha reductase in a beneficial way. Trenbolone's androgenic metabolites are produced through different enzymatic pathways, and blocking 5-AR can paradoxically increase androgenic side effects in certain tissues. Finasteride and dutasteride provide no protective benefit against trenbolone-related hair loss, acne, or prostate effects and may worsen them.
Testosterone
SynergisticA testosterone base is absolutely mandatory when running trenbolone. Despite trenbolone's extreme potency, it does not fulfill all of testosterone's physiological roles -- particularly neurological, sexual, and cardiovascular functions that require adequate DHT and estradiol levels. Most protocols use testosterone at TRT doses (100-200 mg/week) when combined with trenbolone to minimize aromatization and water retention while maintaining essential androgenic support. Running trenbolone without testosterone causes severe sexual dysfunction, lethargy, and mood disturbance.
Cabergoline
SynergisticCabergoline is a dopamine agonist considered essential for prolactin management during trenbolone use. Trenbolone's progestogenic activity elevates prolactin levels, which can cause gynecomastia, lactation, sexual dysfunction, and mood disturbance. Typical dosing is 0.25-0.5 mg twice weekly, adjusted based on bloodwork. Prolactin should be confirmed elevated via blood test before initiating cabergoline -- prophylactic use without bloodwork confirmation is generally discouraged but having it on hand is considered mandatory.
Anastrozole
CompatibleAromatase inhibitors are typically unnecessary for managing trenbolone directly, since trenbolone does not aromatize to estrogen. However, the concurrent testosterone base will aromatize, and AI use may be needed to manage estradiol from that source. Importantly, estrogen management becomes more nuanced with trenbolone because progesterone receptor activation can sensitize breast tissue to even normal estradiol levels, potentially requiring lower estradiol targets than usual.
Clenbuterol
CompatibleClenbuterol is frequently stacked with trenbolone during cutting phases to amplify fat loss. Trenbolone provides the anti-catabolic, muscle-sparing, and nutrient-partitioning effects while clenbuterol adds direct thermogenic and beta-2 agonist-mediated lipolysis. Caution is warranted as both compounds independently increase cardiovascular strain -- heart rate, blood pressure, and cardiac workload should be monitored closely when combining them.
Cardarine
CompatibleCardarine (GW-501516) is commonly used alongside trenbolone to counteract one of its most notorious side effects: severely reduced cardiovascular endurance. Trenbolone substantially impairs aerobic capacity, and cardarine's PPAR-delta agonism can partially restore endurance performance. This combination is popular among users who want trenbolone's anabolic benefits without completely sacrificing conditioning work.
HCG
CompatibleHCG helps maintain testicular function and endogenous testosterone production during trenbolone use. Trenbolone is among the most suppressive anabolic steroids, causing rapid and near-complete shutdown of the hypothalamic-pituitary-testicular axis. Concurrent HCG (500-1000 IU 2-3x per week) can preserve testicular volume and fertility potential, which is particularly important for those planning post-cycle recovery.
Growth Hormone
SynergisticGrowth hormone and trenbolone together produce a powerful recomposition synergy. GH drives lipolysis and IGF-1 production while trenbolone provides extreme anabolic drive and anti-catabolic protection. The combination is widely considered among the most effective for simultaneous lean mass gain and fat loss. Both compounds independently increase IGF-1, and their combined effect on body composition exceeds what either produces alone.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- Week 1 (Acetate)
Trenbolone acetate's short ester produces detectable effects quickly. Increased aggression, assertiveness, and training intensity are often the first signs. Some users report improved muscle hardness and vascularity within days. Side effects can also appear rapidly: insomnia, night sweats, and elevated body temperature are common early indicators. The compound is already influencing nutrient partitioning and nitrogen retention.
- Week 2-3
Significant strength increases become apparent. Visible changes in muscle density and fullness without the water retention associated with aromatizing steroids. Fat loss effects become noticeable, particularly in individuals at moderate body fat levels. Side effects typically intensify: insomnia may become chronic, night sweats more severe, and cardiovascular endurance noticeably reduced. Tren cough episodes may occur with injections.
- Week 4-6
Peak recomposition effects. Dramatic changes in body composition are evident -- pronounced muscle hardness, vascularity, and separation. Strength continues climbing. Nutrient partitioning is at maximum efficiency. This is often when the full scope of side effects manifests: significant insomnia, drenching night sweats, mood changes (increased irritability, anxiety, or aggression), and severely impaired cardiovascular endurance. Prolactin-related symptoms may emerge if not managed.
- Week 6-8
Continued lean mass accrual and strength progression. Body composition changes are substantial and clearly visible. Many users reach their peak aesthetic condition during this window. However, cumulative side effects often become difficult to manage: chronic sleep disruption, cardiovascular strain, and psychological effects may prompt some users to discontinue. Blood pressure and lipid panels are typically at their worst points.
- Week 8-10+ (Cycle Conclusion)
Extended trenbolone cycles beyond 8-10 weeks (acetate) or 10-12 weeks (enanthate) carry progressively increasing health risks with diminishing marginal returns. Cardiovascular biomarkers, lipid profiles, and liver/kidney values are at their most impacted. Most experienced users end trenbolone cycles at this point. Recovery of normal sleep patterns, cardiovascular endurance, and mental well-being typically begins within 1-2 weeks of the final acetate injection or 3-4 weeks after the final enanthate injection.
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Insomnia and severely disrupted sleep architecture (one of the most universally reported side effects, affecting the majority of users)
- Night sweats, often drenching, requiring sheet changes
- Significantly reduced cardiovascular endurance and aerobic capacity
- Increased aggression, irritability, and shortened temper
- Anxiety and restlessness, particularly at higher doses
- Tren cough: acute, intense coughing fit lasting 30-90 seconds immediately after injection, caused by a small amount of oil entering a blood vessel
- Dark-colored urine (oxidized metabolites; not necessarily indicative of kidney damage but should be monitored)
- Elevated body temperature and increased sweating throughout the day
- Acne and oily skin, particularly on shoulders, back, and chest
- Accelerated hair loss in those genetically predisposed to male pattern baldness
- Profoundly suppressive of natural testosterone production (near-complete HPT axis shutdown)
- Increased heart rate and elevated blood pressure
Rare side effects
- Severe cardiovascular events: significant left ventricular hypertrophy, cardiac fibrosis, and accelerated atherosclerosis with prolonged use
- Prolactin-mediated gynecomastia and nipple discharge (lactation)
- Severe mental health deterioration: paranoia, extreme mood swings, relationship-damaging jealousy and possessiveness
- Sexual dysfunction despite adequate testosterone base, typically prolactin-mediated
- Kidney stress (elevated creatinine, though trenbolone's metabolites can artificially elevate creatinine readings on standard assays)
- Liver enzyme elevation, though less hepatotoxic than oral 17-alpha-alkylated steroids
- Tachycardia and heart palpitations at rest
- Severe digestive issues: acid reflux, reduced appetite at high doses
- Erectile dysfunction persisting after cycle if prolactin is not properly managed
Stop signs — stop and seek advice
- Severe insomnia lasting multiple consecutive weeks with no improvement despite sleep hygiene interventions
- Chest pain, pressure, or tightness, particularly during exertion
- Blood pressure consistently above 140/90 mmHg despite management attempts
- Severe mental health changes: pronounced paranoia, uncontrollable aggression, panic attacks, or depressive episodes
- Kidney pain or significantly altered urinary patterns beyond normal dark coloration
- Heart palpitations or irregular heartbeat at rest
- Signs of prolactin-mediated gynecomastia progression despite cabergoline use
- Extreme and persistent shortness of breath unrelated to tren cough
Contraindications
- First steroid cycle or limited anabolic steroid experience (trenbolone is strictly an advanced-only compound)
- Pre-existing cardiovascular disease, cardiomyopathy, or significant cardiac risk factors
- History of mental health conditions: anxiety disorders, depression, bipolar disorder, or psychotic episodes
- Liver disease or significantly elevated liver enzymes
- Kidney disease or impaired renal function
- Uncontrolled hypertension
- Polycythemia (hematocrit above 54% at baseline)
- Prostate cancer or history of hormone-sensitive cancers
- Active or recent substance abuse (trenbolone's psychological effects can exacerbate addictive behaviors)
- Pregnancy or potential for pregnancy in female partners (extremely virilizing compound)
Monitoring
- Complete blood count with hematocrit: baseline and every 4-6 weeks during cycle
- Comprehensive metabolic panel: baseline and every 4-6 weeks (kidney and liver function)
- Lipid panel: baseline and every 4-6 weeks (trenbolone severely impacts HDL/LDL ratio)
- Prolactin: baseline, 3-4 weeks after starting, and as needed based on symptoms
- Estradiol (sensitive assay): at each blood draw to manage aromatization from testosterone base
- Blood pressure: self-monitored at home at least 3x per week throughout cycle
- Cardiac evaluation: echocardiogram recommended before first trenbolone cycle and annually for repeat users
- Fasting glucose and HbA1c: baseline, as trenbolone can influence insulin sensitivity
- Total and free testosterone: to confirm adequate testosterone base
- Kidney function (BUN, creatinine, cystatin C): note that standard creatinine assays can be falsely elevated by trenbolone metabolites; cystatin C provides a more accurate assessment
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- Clear, yellow to amber-colored oil with no visible particles or cloudiness (trenbolone solutions are characteristically darker than most other steroid preparations)
- Properly labeled with compound name, ester type, concentration, batch number, and expiration date
- Concentration within standard range (100-200 mg/mL for acetate; 100-200 mg/mL for enanthate)
- Oil draws smoothly with appropriate viscosity for the carrier oil used
- Third-party laboratory testing (HPLC/mass spectrometry) confirming identity and concentration
- Intact rubber stopper with no signs of prior puncture
Warning signs
- Underground lab product without independent third-party testing or verification
- Concentration claims above 200 mg/mL (higher concentrations frequently cause severe post-injection pain)
- Unusually dark or rust-colored solution (can indicate oxidation or degradation)
- Vial label with spelling errors, inconsistent formatting, or unprofessional appearance
- Product stored in direct sunlight or extreme temperatures (trenbolone degrades faster than most steroids when exposed to UV light)
- No batch number or expiration date on labeling
Stop signs — don't use
- Cloudy, opaque, or particulate-containing solution (contamination risk)
- Crashed product (visible crystallization in the vial)
- Broken or missing tamper-evident seal
- No labeling whatsoever or labeling that does not match the claimed compound
- Solution has turned from yellow/amber to dark brown or red (significant oxidative degradation)
- Severe, persistent injection site pain, redness, or swelling lasting more than 72 hours (potential infection or abscess)
- Product sourced without any testing, batch tracking, or quality assurance
Recent research
Newer papers and trial readouts on file for this compound, with source and date.
January 2023 · The New England Journal of Medicine
Adverse Health Effects of Anabolic-Androgenic Steroids
Comprehensive review of the adverse health effects of anabolic-androgenic steroids, including cardiovascular, hepatic, reproductive, and psychiatric consequences. Highlighted the disproportionate cardiovascular risk associated with highly potent androgens such as trenbolone, including accelerated atherosclerosis, cardiomyopathy, and sudden cardiac death risk.
March 2020 · Toxicology and Applied Pharmacology
Myocardial Dysfunction after Chronic Trenbolone Acetate Administration in Male Rats
Animal study demonstrating that chronic trenbolone acetate exposure causes significant myocardial dysfunction, including reduced ejection fraction, increased cardiac fibrosis, and altered calcium handling in cardiomyocytes. Findings support the clinical observation that trenbolone is particularly cardiotoxic among anabolic steroids.
September 2020 · Psychoneuroendocrinology
Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers
Controlled study examining the psychiatric effects of supraphysiological androgen exposure, documenting dose-dependent increases in irritability, aggression, and manic symptoms. While focused on testosterone, findings are particularly relevant to trenbolone given its five-fold greater androgenic potency and well-documented psychological side effect profile.
References
Primary literature and clinical-trial data informing this entry.
Characterization of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor
Bauer, E.R., Daxenberger, A., Petri, T., et al. · APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica · 2000
Quantified trenbolone's binding affinity to the androgen receptor, confirming it binds with approximately three times the affinity of testosterone. Also characterized its significant progesterone receptor binding, providing mechanistic support for trenbolone's progestogenic side effects including prolactin elevation.
Cardiovascular toxicity of illicit anabolic-androgenic steroid use
Baggish, A.L., Weiner, R.B., Kanayama, G., et al. · Circulation · 2017
Cross-sectional study of 140 experienced strength athletes demonstrating that long-term anabolic steroid use, including trenbolone, was associated with reduced left ventricular systolic function and increased coronary artery plaque volume. Highlighted the significant cardiovascular risks of potent androgens, particularly relevant to trenbolone given its extreme androgenic potency.
Trenbolone, a new potent anabolic agent
Neumann, F. · Journal of Animal Science · 1976
Early characterization of trenbolone's anabolic and androgenic properties in animal models, establishing its potency as approximately five times that of testosterone. Documented its effects on nitrogen retention, feed efficiency, and lean tissue accretion in livestock, forming the pharmacological basis for its veterinary applications.
The effect of trenbolone acetate and zeranol on protein metabolism in male castrate and female lambs
Sinnett-Smith, P.A., Dumelow, N.W., Buttery, P.J. · British Journal of Nutrition · 1983
Demonstrated trenbolone acetate's mechanism of action on protein metabolism, showing significant increases in nitrogen retention and protein synthesis rates while simultaneously decreasing protein degradation. Established the dual anabolic-anticatabolic mechanism that distinguishes trenbolone from many other anabolic agents.
Disposition of trenbolone acetate residues in the edible tissues of cattle and swine following administration of approved and excessive dosages
Lange, I.G., Daxenberger, A., Meyer, H.H.D. · Journal of Animal Science · 2001
Comprehensive pharmacokinetic study of trenbolone acetate metabolism and tissue distribution in livestock. Characterized the metabolic pathways of trenbolone, identifying key metabolites and their tissue-specific distribution, providing important context for understanding trenbolone's pharmacology in human users.
Last updated . How this page was sourced is described in the methodology.